Serum levels of interferons in patients with systemic lupus erythematosus
- PMID: 2449306
- PMCID: PMC1542177
Serum levels of interferons in patients with systemic lupus erythematosus
Abstract
Serum levels of alpha (alpha) and gamma (gamma)-interferons (IFN) were measured in 30 patients with untreated systemic lupus erythematosus (SLE) with a solid-phase, sandwich immunoradiometric assay using specific monoclonal antibodies. The serum levels of alpha-IFN were higher in patients with SLE than in normal subjects, and correlated with the clinical activity index (rs = 0.60, P less than 0.01), but not with renal histological activity. The serum level of alpha-IFN correlated with the serum level of immune complexes (r = 0.46, P less than 0.01) and the number of peripheral lymphocytes inversely (r = -0.49, P less than 0.01). Serum gamma-IFN levels were also higher in patients with SLE than in control subjects but no correlations were found between it and either clinical activity, renal histological activity or various laboratory parameters. Serum levels of both alpha-IFN and gamma-IFN were higher in SLE patients with erythema than in those without. These results suggested that serum levels of alpha-IFN were more closely related to clinical activity of SLE than were those of gamma-IFN, and that peripheral lymphocytes were probably not the source of the elevated serum IFN-alpha concentration.
Similar articles
-
High levels of circulating interferons type I, type II and type III associate with distinct clinical features of active systemic lupus erythematosus.Arthritis Res Ther. 2019 Apr 29;21(1):107. doi: 10.1186/s13075-019-1878-y. Arthritis Res Ther. 2019. PMID: 31036046 Free PMC article.
-
Lymphocyte apoptosis and macrophage function: correlation with disease activity in systemic lupus erythematosus.Clin Rheumatol. 2005 Apr;24(2):107-10. doi: 10.1007/s10067-004-0972-x. Epub 2004 Jul 28. Clin Rheumatol. 2005. PMID: 15818511
-
Peripheral blood lymphocyte apoptosis and circulating dendritic cells in patients with systemic lupus erythematosus: correlation with immunological status and disease-related symptoms.Clin Rheumatol. 2006 Mar;25(2):225-33. doi: 10.1007/s10067-005-1163-0. Epub 2006 Jan 24. Clin Rheumatol. 2006. PMID: 16432661
-
The emerging role of interferon in human systemic lupus erythematosus.Curr Opin Immunol. 2004 Dec;16(6):801-7. doi: 10.1016/j.coi.2004.09.014. Curr Opin Immunol. 2004. PMID: 15511676 Review.
-
Targeting interferons and their pathways in systemic lupus erythematosus.Autoimmun Rev. 2018 Jan;17(1):44-52. doi: 10.1016/j.autrev.2017.11.009. Epub 2017 Nov 4. Autoimmun Rev. 2018. PMID: 29108825 Review.
Cited by
-
Dermatomyositis after interferon alpha treatment.Med Oncol. 2000 Feb;17(1):64-9. doi: 10.1007/BF02826219. Med Oncol. 2000. PMID: 10713663 Review.
-
Detecting shared pathogenesis from the shared genetics of immune-related diseases.Nat Rev Genet. 2009 Jan;10(1):43-55. doi: 10.1038/nrg2489. Nat Rev Genet. 2009. PMID: 19092835 Review.
-
Tubuloreticular Inclusions in the Absence of Systemic Lupus Erythematosus and HIV Infection: A Report of Three Pediatric Cases.Case Rep Nephrol Dial. 2017 Jun 23;7(2):91-101. doi: 10.1159/000477661. eCollection 2017 May-Aug. Case Rep Nephrol Dial. 2017. PMID: 28868299 Free PMC article.
-
Distinct autoantibody profiles in systemic lupus erythematosus patients are selectively associated with TLR7 and TLR9 upregulation.J Clin Immunol. 2013 Jul;33(5):954-64. doi: 10.1007/s10875-013-9887-0. Epub 2013 Apr 7. J Clin Immunol. 2013. PMID: 23564191
-
Natural killer cell activity in Sjögren's syndrome and systemic lupus erythematosus: stimulation with interferons and interleukin-2 and correlation with immune complexes.Ann Rheum Dis. 1990 Sep;49(9):690-3. doi: 10.1136/ard.49.9.690. Ann Rheum Dis. 1990. PMID: 1700674 Free PMC article.
References
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical